Form 4: Replimune Director Exercises, Sells Shares

Replimune Group, Inc. director Kapil Dhingra exercised stock options and immediately sold the acquired common stock.

Summary

• Kapil Dhingra, a Director of Replimune Group, Inc. (REPL), executed a transaction involving the company's common stock.
• On December 9, 2025, Dhingra exercised 3,169 stock options at an exercise price of $1.75 per share.
• Concurrently, Dhingra disposed of 3,169 shares of common stock at a price of $10.40 per share.
• The option exercise was due to the upcoming expiration date of the option, which was January 21, 2026.
• All shares underlying the stock option had vested on January 21, 2016.
• Following these transactions, Dhingra's direct beneficial ownership of common stock is 0 shares.

Sentiment

Score: 5

Explanation: The transaction is a routine insider exercise and sell, often for liquidity or tax planning, and does not inherently signal a positive or negative fundamental change for the company.

Positives

• The director realized a gain from exercising options at $1.75 and selling shares at $10.40, indicating a profitable transaction for the individual.

Negatives

• The transaction represents insider selling, which some investors may interpret negatively, although it is a common practice for option exercises.

Risks

• No specific company-level risks were disclosed in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as the exercise of stock options and subsequent sale of shares, are a common occurrence across all industries, often driven by personal financial planning, liquidity needs, or the impending expiration of options.

Related Party Transactions

• A director, Kapil Dhingra, engaged in transactions involving the company's equity securities by exercising stock options and selling the resulting common shares.

Stakeholder Impact

• Shareholders might observe insider selling, which can sometimes be perceived negatively, though in this case, it's an exercise-and-sell transaction often tied to option expiration or personal financial management.

Key Dates

Recommendation

The filing details a routine insider transaction where a director exercised expiring stock options and immediately sold the shares. This type of transaction is common for liquidity or tax planning and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this report.

Keywords

Replimune, REPL, Form 4, insider transaction, stock option, share sale, director, Kapil Dhingra